The Federal Trade Commission (FTC) asked a federal judge in the Southern District of New York last month to hold Shkreli in civil contempt of court for breaching a lifetime restraining order preventing him from working in the pharma industry, after he set up a company called Druglike.
Now, in a statement to the court, Shkreli has claimed that Druglike is not engaged in drug discovery, so doesn’t breach the terms of his restraining order.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,